FFCP PHASE2:Hg19::chr1:226111929..226112026,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@LEFTY1, p1@PYCR2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_LEFTY1_5end, CAGE_peak_1_at_PYCR2_5end |
Coexpression cluster: | NA |
Association with transcript: | 0bp_to_ENST00000316918, ENST00000343818, ENST00000366823, ENST00000432920, ENST00000478402, NM_013328, uc001hpq.2, uc001hpr.2, uc010pvj.1_5end |
EntrezGene: | 29920,10637 |
HGNC: | 6552&submit=Submit 30262, 6552 |
UniProt: | A6NMB5Q96C36P32322 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@LEFTY1p1@PYCR2 |
---|
0
50
100
150
200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematologic cancer | 1.41e-20 | 51 |
immune system cancer | 1.41e-20 | 51 |
leukemia | 1.66e-18 | 39 |
cancer | 3.19e-18 | 235 |
disease of cellular proliferation | 7.54e-18 | 239 |
myeloid leukemia | 1.06e-15 | 31 |
organ system cancer | 2.86e-11 | 137 |
carcinoma | 4.47e-07 | 106 |
Showing 1 to 8 of 8 entries